FundedIQ
Biotechnology

IMMvention Therapeutix: Funding, Investors & Team (Oct 2026)

stealthy venture-funded business for the treatment of inflammatory illnesses, finding and creating new, first-in-class small molecule pan-inflammasome inhibitors

immventionthera.com LinkedIn Chapel Hill, United States 11-50 employees
Biotechnology Health Care Therapeutics B2B Inflammation Inflammasomes Immunology And cytokines
Total raised
$2.0M
Rounds
1
Latest
Undisclosed round
Jan 2023

IMMvention Therapeutix has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Jan 2023.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

IMMvention Therapeutix Company Profile and Key Stats

Total funding raised
$2.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$2.0M in Jan 2023
Employees
11-50
reported band
Headquarters
Chapel Hill, United States

Latest funding round on record: Jan 2023.

IMMvention Therapeutix Funding Rounds

Date
Round
Amount
Undisclosed round
$2.0M

IMMvention Therapeutix Founders and Leadership Team

Name
Role
Contact
Anil Goyal
CEO
Locked

Contact details for the IMMvention Therapeutix team: 1 of 1 has an email address on file.

Start 14-day free trial →

IMMvention Therapeutix Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

IMMvention Therapeutix's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like IMMvention Therapeutix in Biotechnology and Chapel Hill

Companies Similar to IMMvention Therapeutix

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

IMMvention Therapeutix Funding FAQs

What does IMMvention Therapeutix do?

stealthy venture-funded business for the treatment of inflammatory illnesses, finding and creating new, first-in-class small molecule pan-inflammasome inhibitors

How much funding has IMMvention Therapeutix raised?

IMMvention Therapeutix has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Jan 2023.

When did IMMvention Therapeutix last raise funding?

IMMvention Therapeutix's most recent funding round on record is an undisclosed round of $2.0M, announced in Jan 2023.

Who is the CEO of IMMvention Therapeutix?

Anil Goyal is listed as CEO at IMMvention Therapeutix.

Where is IMMvention Therapeutix headquartered?

IMMvention Therapeutix is based in Chapel Hill, North Carolina, United States.

How many employees does IMMvention Therapeutix have?

IMMvention Therapeutix is in the 11-50 employee band.

How does IMMvention Therapeutix's funding compare to other Biotechnology startups?

IMMvention Therapeutix's latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's IMMvention Therapeutix Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IMMvention Therapeutix is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.